Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus

The Next WebPublished Jun 6, 2026

Reid Hoffman has resigned from Microsoft's board to focus on leading Manus, an AI-driven drug discovery startup. This move marks his shift towards entrepreneurship in the AI healthcare sector.

#ai-drug-discovery #manus #microsoft #reid-hoffman

Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus

More in Healthcare

Healthcare AI Agents Are Here—The Hugging Face Hack Shows Why They Need Guardrails

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors